Logo image of ISRA

VANECK ISRAEL ETF (ISRA) Stock Overview

USA - NYSEARCA:ISRA - US92189F6354 - ETF

53.111 USD
-0.07 (-0.13%)
Last: 9/12/2025, 4:15:00 PM
Fundamental Rating

5

ISRA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 80 industry peers in the Automobile Components industry. ISRA has only an average score on both its financial health and profitability. ISRA is not valued too expensively and it also shows a decent growth rate. ISRA also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ISRA was profitable.
ISRA had a positive operating cash flow in the past year.
In the past 5 years ISRA has always been profitable.
Each year in the past 5 years ISRA had a positive operating cash flow.
ISRA Yearly Net Income VS EBIT VS OCF VS FCFISRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

ISRA has a Return On Assets (4.39%) which is in line with its industry peers.
The Return On Equity of ISRA (8.81%) is comparable to the rest of the industry.
The Return On Invested Capital of ISRA (8.17%) is comparable to the rest of the industry.
ISRA had an Average Return On Invested Capital over the past 3 years of 9.25%. This is in line with the industry average of 8.51%.
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROIC 8.17%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ISRA Yearly ROA, ROE, ROICISRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ISRA's Profit Margin of 5.84% is in line compared to the rest of the industry. ISRA outperforms 60.00% of its industry peers.
In the last couple of years the Profit Margin of ISRA has remained more or less at the same level.
The Operating Margin of ISRA (10.65%) is better than 61.25% of its industry peers.
ISRA's Operating Margin has been stable in the last couple of years.
ISRA has a Gross Margin (27.60%) which is comparable to the rest of the industry.
ISRA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
ISRA Yearly Profit, Operating, Gross MarginsISRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ISRA is creating some value.
The number of shares outstanding for ISRA has been reduced compared to 1 year ago.
ISRA has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ISRA has a worse debt to assets ratio.
ISRA Yearly Shares OutstandingISRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ISRA Yearly Total Debt VS Total AssetsISRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

ISRA has an Altman-Z score of 2.96. This is not the best score and indicates that ISRA is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.96, ISRA is doing good in the industry, outperforming 67.50% of the companies in the same industry.
The Debt to FCF ratio of ISRA is 6.05, which is on the high side as it means it would take ISRA, 6.05 years of fcf income to pay off all of its debts.
ISRA's Debt to FCF ratio of 6.05 is in line compared to the rest of the industry. ISRA outperforms 46.25% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that ISRA is not too dependend on debt financing.
ISRA's Debt to Equity ratio of 0.32 is in line compared to the rest of the industry. ISRA outperforms 48.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Altman-Z 2.96
ROIC/WACC1.15
WACC7.12%
ISRA Yearly LT Debt VS Equity VS FCFISRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.80 indicates that ISRA should not have too much problems paying its short term obligations.
ISRA has a worse Current ratio (1.80) than 62.50% of its industry peers.
A Quick Ratio of 1.12 indicates that ISRA should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.12, ISRA is doing worse than 63.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.12
ISRA Yearly Current Assets VS Current LiabilitesISRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The earnings per share for ISRA have decreased strongly by -18.28% in the last year.
Measured over the past 5 years, ISRA shows a small growth in Earnings Per Share. The EPS has been growing by 1.64% on average per year.
Looking at the last year, ISRA shows a decrease in Revenue. The Revenue has decreased by -3.62% in the last year.
Measured over the past years, ISRA shows a small growth in Revenue. The Revenue has been growing by 2.41% on average per year.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%

3.2 Future

ISRA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.31% yearly.
ISRA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.56% yearly.
EPS Next Y22.75%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
EPS Next 5YN/A
Revenue Next Year-1.64%
Revenue Next 2Y0.47%
Revenue Next 3Y1.52%
Revenue Next 5Y2.56%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ISRA Yearly Revenue VS EstimatesISRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
ISRA Yearly EPS VS EstimatesISRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

ISRA is valuated rather expensively with a Price/Earnings ratio of 20.75.
ISRA's Price/Earnings is on the same level as the industry average.
ISRA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.43.
A Price/Forward Earnings ratio of 12.16 indicates a correct valuation of ISRA.
ISRA's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, ISRA is valued a bit cheaper.
Industry RankSector Rank
PE 20.75
Fwd PE 12.16
ISRA Price Earnings VS Forward Price EarningsISRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ISRA.
ISRA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 25.87
EV/EBITDA 7.39
ISRA Per share dataISRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

ISRA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ISRA's earnings are expected to grow with 16.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.91
PEG (5Y)12.63
EPS Next 2Y19.47%
EPS Next 3Y16.31%

7

5. Dividend

5.1 Amount

ISRA has a Yearly Dividend Yield of 4.49%, which is a nice return.
ISRA's Dividend Yield is rather good when compared to the industry average which is at 3.98. ISRA pays more dividend than 85.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, ISRA pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.49%

5.2 History

On average, the dividend of ISRA grows each year by 7.84%, which is quite nice.
ISRA has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.84%
Div Incr Years0
Div Non Decr Years0
ISRA Yearly Dividends per shareISRA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

62.40% of the earnings are spent on dividend by ISRA. This is not a sustainable payout ratio.
ISRA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.4%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
ISRA Yearly Income VS Free CF VS DividendISRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
ISRA Dividend Payout.ISRA Dividend Payout, showing the Payout Ratio.ISRA Dividend Payout.PayoutRetained Earnings

VANECK ISRAEL ETF

NYSEARCA:ISRA (9/12/2025, 4:15:00 PM)

53.111

-0.07 (-0.13%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)02-22 2026-02-22/amc
Inst Owners39.91%
Inst Owner Change-14.24%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap37.48B
Analysts80.87
Price Target58.09 (9.37%)
Short Float %0%
Short Ratio1.59
Dividend
Industry RankSector Rank
Dividend Yield 4.49%
Yearly Dividend1.58
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.96%
PT rev (3m)8.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.31%
EPS NY rev (3m)-9.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)-2.45%
Valuation
Industry RankSector Rank
PE 20.75
Fwd PE 12.16
P/S 1.2
P/FCF 25.87
P/OCF 9.48
P/B 1.81
P/tB 2.46
EV/EBITDA 7.39
EPS(TTM)2.56
EY4.82%
EPS(NY)4.37
Fwd EY8.23%
FCF(TTM)2.05
FCFY3.87%
OCF(TTM)5.6
OCFY10.55%
SpS44.27
BVpS29.34
TBVpS21.6
PEG (NY)0.91
PEG (5Y)12.63
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROCE 10.41%
ROIC 8.17%
ROICexc 9.37%
ROICexgc 11.66%
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
FCFM 4.64%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Debt/EBITDA 1.17
Cap/Depr 107.96%
Cap/Sales 8.01%
Interest Coverage 9.96
Cash Conversion 70%
Profit Quality 79.44%
Current Ratio 1.8
Quick Ratio 1.12
Altman-Z 2.96
F-Score5
WACC7.12%
ROIC/WACC1.15
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y22.75%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-1.64%
Revenue Next 2Y0.47%
Revenue Next 3Y1.52%
Revenue Next 5Y2.56%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year66.93%
EBIT Next 3Y23.28%
EBIT Next 5Y17.51%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%